Cite

HARVARD Citation

    Cubas, R. et al. (2020). Autoimmunity linked protein phosphatase PTPN22 as a target for cancer immunotherapy. Journal for immunotherapy of cancer. 8 (2), p. . [Online]. 
  
Back to record